Biogen Inc. buy Royal Bank of Canada
Start price
22.04.25
/
50%
€103.25
Target price
22.04.26
€195.75
Performance (%)
31.09%
Price
03.10.25
€135.35
Summary
This prediction is currently active. With a performance of 31.09% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 22.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 15.241% | 15.241% |
| iShares Core DAX® | 2.709% | 3.467% |
| iShares Nasdaq 100 | 0.867% | 5.198% |
| iShares Nikkei 225® | 3.135% | 9.423% |
| iShares S&P 500 | 0.886% | 3.586% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $221.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat